Guidelines continue to strongly recommend co-testing in women ages 30 to 651-5
Evidence-based guidelines from many leading health organizations support the importance of co-testing:
|Ages 21-29||Ages 30-65||Ages > 65|
|ACOG3,4||Level A: ||Level A: ||Screening should be discontinued if patient has had adequate negative prior screening results and no history of CIN2+. Recommend continuing age-based screening for ≥20 years in those patients with a history of CIN2, CIN3, or adenocarcinoma in situ. Adequate negative prior screening results is defined as 3 consecutive negative Paps or 2 consecutive negative co-tests within the past 10 years, with the most recent test occurring within the past 5 years.|
|USPSTF2||Grade A: Pap alone every 3 years||Grade A: |
|Recommends: Pap alone every 3 years||Recommends: ||No comments|
NOTE: This table is a summary for convenience and should not be considered complete. For complete details, please see the respective guidelines.
ACOG = American College of Obstetricians and Gynecology; USPSTF = United States Preventive Services Task Force; HRSA = Health Resources & Services Administration; WPSI = Women’s Preventive Services InitiativeReferences
- American College of Obstetricians and Gynecologists. Practice advisory: cervical cancer screening (update). Published August 21, 2018. Accessed May 17, 2019. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2018/08/cervical-cancer-screening-update.
- US Preventive Services Task Force. Final recommendation statement. Cervical cancer: screening. Updated August 2018. Accessed May 17, 2019. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical-cancer-screening2.
- American College of Obstetricians and Gynecologists. Practice bulletin no. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. 2013;122(6):1338-1367. doi:10.1097/01.AOG.0000438960.31355.9e
- Committee on Practice Bulletins—Gynecology. Practice bulletin no. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128(4):e111-e130. doi:10.1097/AOG.0000000000001708
- Health Resources & Services Administration. Women’s preventive services guidelines. Last reviewed September 2018. Accessed June 10, 2019. https://www.hrsa.gov/womens-guidelines/index.html.